2º antiTNF +/- Azathioprine in IBD patients who had immune mediated LOR to first antiTNF
2º antiTNF +/- Azathioprine in IBD patients who had immune mediated LOR to first antiTNF
Low FODMAP trial on Symptoms, Fecal Microbiome, and Markers of Inflammation in Patients With Quiescent Inflammatory Bowel Disease